Changes in Health Tech Investment Focus After Midterms

November 10, 2026 - 05:41

In the aftermath of the midterm elections, health tech investors are realigning their priorities, signaling a shift towards key policy reforms. One of the most pressing issues is the need for reform in pharmacy benefit managers, or PBMs. Investors are increasingly recognizing the role of PBMs in shaping drug pricing and access, pushing for changes that could enhance transparency and accountability in the pharmaceutical supply chain.

the demand for permanent telehealth flexibilities is gaining traction. The pandemic highlighted the importance of remote healthcare services, and many stakeholders are advocating for policies that ensure these options remain accessible long-term. This shift could lead to broader adoption of telehealth technologies, ultimately improving patient care and reducing costs.

Lastly, there is a growing call for tighter oversight at the state level. As health tech continues to evolve, investors are looking for regulatory frameworks that promote innovation while ensuring patient safety and equitable access to healthcare services. This combination of reforms could reshape the landscape of health technology in the coming years.